Mainz Biomed N.V. (MYNZ): Utang-utang marang kapitalisasi buku

Mainz Biomed N.V. is implementing robotics for the precision analysis of biomaterials to minimize human error. Diversification through colorectal cancer tests in the US and Europe ensures stable sales. The trajectory of the company's financial leverage reflects borrowing dynamics, where the 1.24 indicator determines the metric's magnitude. Optimized air freight of kits guarantees clients an uninterrupted supply without delays.

Mainz Biomed (MYNZ) - Utang-utang marang nilai buku saka 04.07.2022 nganti 11.03.2026

Rincian metrik lan analitis perusahaan mainzbiomed.com (MYNZ)

- rega lan prakiraan konsensus rega:

Bagan rega Mainz Biomed N.V.|MYNZ - Prakiraan gabungan firma investasi

- data kapitalisasi pasar:

Kapitalisasi pasar Mainz Biomed|MYNZ - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data kapitalisasi buku:

Nilai Buku saben Saham Mainz Biomed|MYNZ - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku mainzbiomed.com|MYNZ - Nilai Agregat Aset

- data utang lan likuiditas:

Rasio Total Utang marang Ekuitas Mainz Biomed N.V.|MYNZ - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Mainz Biomed|MYNZ - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Mainz Biomed|MYNZ - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Mainz Biomed

Ringkesan analitik perusahaan:MYNZ - Mainz Biomed N.V.

This indicator determines the degree of business dependence on borrowed funds relative to equity. By analyzing the financial leverage trend chart for Mainz Biomed N.V. (MYNZ), an investor assesses the balance sheet structure's resilience to external shocks. A low ratio confirms the high autonomy of Mainz Biomed N.V. (MYNZ) while scaling the ColoAlert test. Growing confidence among physicians in the US and Europe reduces liquidity deficit risks, ensuring the fundamental reliability of the asset.

Pesaing Mainz Biomed N.V.

CAI - Rasio utang marang kapitalisasi buku|Rasio utang marang nilai buku guardanthealth.com GH|VCYT: Utang-utang marang kapitalisasi buku|CELC - Utang marang nilai buku|Utang-utang marang kapitalisasi buku GRAL|MYGN (Myriad) - Utang-utang marang nilai buku|CSTL - Rasio utang marang kapitalisasi buku|Rasio utang marang aset resik brbiotech.com (BNR)|VolitionRx Limited (VNRX) - Utang marang nilai buku|Rasio utang marang aset resik Biodesix Inc (BDSX)|Utang-utang marang kapitalisasi buku PRPO (Precipio, Inc)|Check-Cap Ltd - Utang-utang marang kapitalisasi buku|OncoCyte Corporation (OCX) - Rasio utang marang kapitalisasi buku